ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: PO0860

Urgent Training with the Tablo Hemodialysis System in Response to COVID-19

Session Information

Category: Coronavirus (COVID-19)

  • 000 Coronavirus (COVID-19)


  • Aragon, Michael A., Outset Medical, Inc., San Jose, California, United States
  • Gilliland, Michelle L., Outset Medical, Inc., San Jose, California, United States
  • Maynard, Marc, Outset Medical, Inc., San Jose, California, United States

During the COVID-19 pandemic, many facilities experienced dialysis resource shortages of specialized dialysis staff, sterile dialysate, dialysis systems, and treatment locations. The Tablo® Hemodialysis System was deployed in numerous hospitals to help meet the increased need for dialysis delivery.

Tablo is an all-in-one, easy-to-learn system indicated for clinic, hospital and home settings. Features include integrated water purification, on demand dialysate production, simplified user interface and two-way wireless connectivity. Tablo’s clinical versatility and simplicity allow for broad prescribing and treatment location options.

The objective is to report on Tablo training effectiveness during urgent deployment to facilities amidst the COVID-19 pandemic.


Standard training with Tablo (< 4 hours) was performed during the peak COVID months of March through May at 51 facilities. Information regarding nursing experience and current role was recorded. Nursing staff trained on Tablo in May completed an electronic survey post-training. Based on a Likert scale ranging from Strongly Agree to Strongly Disagree, respondents rated their satisfaction with training, system ease of use, and confidence performing dialysis independently post training.


Of 926 clinicians trained, 854 were registered nurses (RNs). 136 RNs completed the survey and were representative of the entire group (49% vs 47% ICU, 35% vs 34% HD, 11% vs 16% Non ICU/Non HD). Responses of Strongly Agree or Agree are presented in Table 1 by experience and current role.


Nurses of varied experience and areas of focus trained on Tablo during the pandemic reported: high levels of satisfaction with training, the device was easy to use, and confidence in providing treatment to patients. The Tablo Hemodialysis System can allow training of existing staff to efficiently expand a facility’s renal replacement capabilities.

Table 1 - Tablo Training Survey Responses
RNEXPI am Satisfied with Tablo TrainingI Found Tablo Easy to Learn and UseI am confident Treating with Tablo Independently
HD≤ 5yrs100% (8/8)100% (8/8)100% (8/8)
> 5yrs100% (39/39)97.4% (38/39)82.1% (32/39)
ICU≤ 5yrs100% (24/24)95.8% (23/24)75% (18/24)
> 5yrs93% (40/43)93% (40/43)76.7% (33/43)
Neither≤ 5yrs100% (7/7)100% (7/7)100% (7/7)
> 5yrs100% (15/15)80% (12/15)100% (15/15)
Overall97.8% (133/136)94.1% (128/136)83.1% (113/136)


  • Commercial Support